KZA
Kazia Therapeutics
- Short interest
- <0.01%
- 0.00 pp 30d
- as of 1 Nov 2023
- Reported shorts
- 1
- Shares on issue
- 236.349M
Kazia Therapeutics (KZA) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for KZA (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Notice of Annual General Meeting/Proxy FormAgm Address3 Nov 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Oct 2023via asx_announcements
- Appendix 4E and 2023 Annual ReportAnnual Results31 Aug 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow Report - updatedQuarterly Report9 May 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Apr 2023via asx_announcements
- Half Yearly Report and AccountsHalf Year Results28 Feb 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report15 Feb 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jan 2023via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Oct 2022via asx_announcements
Showing 10 of 18 reports